21st.BIO Competitors and Similar CompaniesClear all

Centogene's competitors and similar companies include Codexis and CN Bio.

	Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases.	Codexis Codexis is a protein engineering company that develops enzymes for pharmaceutical, food, and medical applications.	CN Bio CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research.
Founding Date	Founding Date 2005	Founding Date 2002	Founding Date 2008
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Technology bioengineering biotech genetics medical diagnostics platform	Tags Technology bioengineering biotech pharma platform	Tags Technology bioengineering biotech drug development medtech platform
Locations	Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more	Locations Redwood City, US HQ	Locations Milton, GB HQ
Employees	Employees 80823% increase	Employees 1888% increase	Employees 576% increase
Valuation ($)	Valuation ($) 9.4 m	Valuation ($) 226.3 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €48.5m (FY, 2023)	Revenue (est.) $70.4m (FY, 2025)	Revenue (est.) £3.5m (FY, 2024)
Cost of goods	Cost of goods €29.1m (FY, 2023)	Cost of goods $9.3m (FY, 2025)	Cost of goods £1.4m (FY, 2024)
Gross profit	Gross profit €23.7m (FY, 2023)	Gross profit $61m (FY, 2025)	Gross profit £2.1m (FY, 2024)
Net income	Net income (€35.5m) (FY, 2023)	Net income ($44m) (FY, 2025)	Net income (£6.3m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 29.6m	Total funding raised $ 87m	Total funding raised $ 11.5m